• Issues regarding access to and reimbursement of proton therapy, including through Medicare and Medicare Advantage.
• Issues regarding access to proton therapy; Issues regarding the Radiation Oncology Alternative Payment Model (RO APM); Issues related to Medicare Prior Authorization.
• Issues regarding access to proton therapy; including in H.R.5894/S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024.
• Issues pertaining to veterans' access to proton therapy.

Duration: October 1, 2019 to present

General Issues: Medicare/Medicaid, Health Issues, Budget/Appropriations, Veterans

Spending: about $1,060,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: House of Representatives, U.S. Senate, White House Office, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Centers For Disease Control & Prevention (CDC)